In addition, GR and GLCCI1 gene polymorphisms may be associated with baseline disease activity in RA, suggesting that differences in the response to endogenously produced GC are also partly mediated via GR and GLCCI1 gene polymorphisms. This evidence concerns the gene GLCCI1 and rheumatoid arthritis.